Last updated: December 13, 2017
Sponsor: Brainmarc Ltd.
Overall Status: Trial Status Unknown
Phase
N/A
Condition
Alzheimer's Disease
Memory Problems
Dementia
Treatment
N/AClinical Study ID
NCT03375151
CLD13
Ages 65-120 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female above the age of 65 years
Ability to read, write and understand the Hebrew language so to comply with studydemands.
Diagnosed with Amnestic MCI. Mini Mental State Examination (MMSE), A score of MSSE ≥27for college educated subjects and MSSE ≥ 26 for all others; and (CDR) ClinicalDementia Rating, 0.5 ≥ CDR
Diagnosed with memory impairment, Visual Paired Association = VPA (WMS-R), forsubjects of ages 65-70, 16.5 ≥ WMS-R and for subjects of age above 71, 15.5 ≥ WMS-R
Exclusion
Exclusion Criteria:
Diagnosed with major psychiatric or neurological disorder.
A user of recreational or illicit drugs or has had a recent history of drug or alcoholabuse or dependence.
Study Design
Total Participants: 60
Study Start date:
February 01, 2018
Estimated Completion Date:
April 30, 2019